Zupkó, I.; Molnár, J.; Réthy, B.; Minorics, R.; Frank, É.; Wölfling, J.; Molnár, J.; Ocsovszki, I.; Topcu, Z.; Bitó, T.;
et al. Anticancer and Multidrug Resistance-Reversal Effects of Solanidine Analogs Synthetized from Pregnadienolone Acetate. Molecules 2014, 19, 2061-2076.
https://doi.org/10.3390/molecules19022061
AMA Style
Zupkó I, Molnár J, Réthy B, Minorics R, Frank É, Wölfling J, Molnár J, Ocsovszki I, Topcu Z, Bitó T,
et al. Anticancer and Multidrug Resistance-Reversal Effects of Solanidine Analogs Synthetized from Pregnadienolone Acetate. Molecules. 2014; 19(2):2061-2076.
https://doi.org/10.3390/molecules19022061
Chicago/Turabian Style
Zupkó, István, Judit Molnár, Borbála Réthy, Renáta Minorics, Éva Frank, János Wölfling, Joseph Molnár, Imre Ocsovszki, Zeki Topcu, Tamás Bitó,
and et al. 2014. "Anticancer and Multidrug Resistance-Reversal Effects of Solanidine Analogs Synthetized from Pregnadienolone Acetate" Molecules 19, no. 2: 2061-2076.
https://doi.org/10.3390/molecules19022061
APA Style
Zupkó, I., Molnár, J., Réthy, B., Minorics, R., Frank, É., Wölfling, J., Molnár, J., Ocsovszki, I., Topcu, Z., Bitó, T., & Puskás, L. G.
(2014). Anticancer and Multidrug Resistance-Reversal Effects of Solanidine Analogs Synthetized from Pregnadienolone Acetate. Molecules, 19(2), 2061-2076.
https://doi.org/10.3390/molecules19022061